Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Chemical Abortion

Chemical Abortion

71 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
71 results
featured-image
Chemical Abortion

Written Testimony of George Delgado, M.D., F.A.A.F.P., in Support of Colorado Abortion Pill Reversal Bill

On Thursday, February 9, 2017, the Colorado House Health, Insurance and Environment Committee held a hearing regarding House Bill 1086 (HB 1086), the Abortion Pill Reversal Information Act. HB 1086 provides that prior to initiating a chemical abortion, a physician must alert the woman to the fact that it may be possible to reverse the abortion should she change her mind and that information on the possibility of reversal is available in state-prepared materials.

George Delgado, M.D., F.A.A.F.P.
February 16, 2017
ClosePlease login
featured-image
Chemical Abortion

Bicameral Congressional Letter Demands Transparency from FDA

Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent a letter to the Commissioner of the Food and Drug Administration demanding answers to questions about the FDA’s surprise approval of relaxed protocols for the distribution of the abortion-inducing drug regimen known as Mifeprex.

Chemical Abortion

Medication Abortion: FDA Guidelines and Personal Experience

Last week, the Food and Drug Administration (FDA) changed the regulations for RU-486, the “abortion pill,” allowing its use up to 70 days into pregnancy, three weeks past the previous guidelines. On the same day, Abby Johnson’s The Walls Are Talking: Former Abortion Clinic Workers Tell Their Stories, was officially released. One chapter in particular stood out as especially timely in regards to the news: “Medication Abortion.”

featured-image
Chemical Abortion

A Pro-Life Setback in Iowa

Pro-lifers received some disappointing news last Friday when the Iowa Supreme Court unanimously struck down Iowa’s telemed abortion ban.

featured-image
Chemical Abortion

A Second Chance at Life: Reversing the Abortion Pill

Abortion Rill Reversal (APR) is a program that seeks to provide medical support to women who have taken mifepristone, the first of two drugs in the RU-486 abortion regimen, and then changed their minds, wanting to continue their pregnancy and save their baby’s life. APR connects with these women through its website (www.abortionpillreversal.com) and a 24/7 emergency hotline (877-558-0333) staffed by nurses and an international network of doctors and pregnancy medical clinic (PMC) hubs.

featured-image
Chemical Abortion

Suspension of Telemed Abortion Ban Puts Iowa Women at Risk

Last week an Iowa district court agreed to temporarily suspend the ban on tele-med abortions, allowing abortion mega-provider Planned Parenthood to continue to distribute abortion inducing drugs while the organization challenges the ban on the practice in court.

featured-image
Chemical Abortion

12th Anniversary of RU-486, a Somber Commemoration

Last week marked the 12th anniversary of the approval for use in the United States of the abortion drug RU- 486.  However, unlike other notable moments in medical history such as the discovery of penicillin in 1928 and the development of the polio vaccine in 1955, RU-486, or mifepristone, calls for a far more sobering memorial. 

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image